Resources
Plasmid Files

pBluescript-FL

cDNA cloning vector derived from pBluescript II KS(-) by replacing the SmaI site with a fragment containing two PflMI sites.

To see this sequence with restriction sites, features, and translations, please download
 SnapGene or the free  SnapGene Viewer.

pBluescript-FL Sequence and MappBluescript-FL.dna
Map and Sequence File   
Sequence Author:  I.M.A.G.E. Consortium
Download Free Trial Get SnapGene Viewer

 XmnI (2669) BsaHI (2607) ScaI (2550) TatI (2548) NmeAIII (2218) BpmI (2140) BsaI (2131) AhdI (2070) AlwNI (1593) NgoMIV (129) NaeI (131) BtgZI (229) BsaAI (234) DraIII (237) AanI - PsiI (362) M13 fwd Eco53kI (655) SacI (657) BtgI (661) AleI (663) SacII (664) BstXI (665) EagI - NotI (670) XbaI (677) SpeI (683) BamHI (689) PflMI (699) SfiI (709) MscI (712) PflMI (719) PstI (729) EcoRI (731) EcoRV (739) HindIII (743) BspDI - ClaI (750) SalI (758) AccI (759) HincII (760) AbsI - AvaI - BsoBI - PaeR7I - PspXI - XhoI (764) BmeT110I (765) EcoO109I - PspOMI (773) ApaI (777) Acc65I (779) KpnI (783) T3 promoter lac operator BspQI - SapI (1061) AflIII - PciI (1177) NspI (1181) pBluescript-FL 2985 bp
XmnI  (2669)
1 site
G A A N N N N T T C C T T N N N N A A G
BsaHI  (2607)
1 site
G R C G Y C C Y G C R G

BsaHI is typically used at 37°C, but is even more active at 60°C.
ScaI  (2550)
1 site
A G T A C T T C A T G A
TatI  (2548)
1 site
W G T A C W W C A T G W
NmeAIII  (2218)
1 site
G C C G A G ( N ) 18-19 N N C G G C T C ( N ) 18-19

Efficient cleavage requires at least two copies of the NmeAIII
recognition sequence.
Sticky ends from different NmeAIII sites may not be compatible.
For full activity, add fresh S-adenosylmethionine (SAM).
BpmI  (2140)
1 site
C T G G A G ( N ) 14 N N G A C C T C ( N ) 14

Efficient cleavage requires at least two copies of the BpmI
recognition sequence.
Sticky ends from different BpmI sites may not be compatible.
After cleavage, BpmI can remain bound to DNA and alter its
electrophoretic mobility.
BpmI quickly loses activity at 37°C.
BsaI  (2131)
1 site
G G T C T C N C C A G A G N ( N ) 4

Sticky ends from different BsaI sites may not be compatible.
BsaI can be used between 37°C and 50°C.
AhdI  (2070)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
AlwNI  (1593)
1 site
C A G N N N C T G G T C N N N G A C

Sticky ends from different AlwNI sites may not be compatible.
NgoMIV  (129)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NgoMIV
recognition sequence.
NaeI  (131)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NaeI
recognition sequence.
BtgZI  (229)
1 site
G C G A T G ( N ) 10 C G C T A C ( N ) 10 ( N ) 4

Sticky ends from different BtgZI sites may not be compatible.
After cleavage, BtgZI can remain bound to DNA and alter its
electrophoretic mobility.
BtgZI is typically used at 60°C, but is 75% active at 37°C.
BsaAI  (234)
1 site
Y A C G T R R T G C A Y
DraIII  (237)
1 site
C A C N N N G T G G T G N N N C A C

Sticky ends from different DraIII sites may not be compatible.
AanI  (362)
1 site
T T A T A A A A T A T T
PsiI  (362)
1 site
T T A T A A A A T A T T
Eco53kI  (655)
1 site
G A G C T C C T C G A G
SacI  (657)
1 site
G A G C T C C T C G A G
BtgI  (661)
1 site
C C R Y G G G G Y R C C

Sticky ends from different BtgI sites may not be compatible.
AleI  (663)
1 site
C A C N N N N G T G G T G N N N N C A C
SacII  (664)
1 site
C C G C G G G G C G C C

Efficient cleavage requires at least two copies of the SacII
recognition sequence.
BstXI  (665)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
EagI  (670)
1 site
C G G C C G G C C G G C
NotI  (670)
1 site
G C G G C C G C C G C C G G C G
XbaI  (677)
1 site
T C T A G A A G A T C T
SpeI  (683)
1 site
A C T A G T T G A T C A
BamHI  (689)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF™ (but not the original BamHI) can
remain bound to DNA and alter its electrophoretic mobility.
PflMI  (699)
2 sites
C C A N N N N N T G G G G T N N N N N A C C

Sticky ends from different PflMI sites may not be compatible.
SfiI  (709)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI
recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
MscI  (712)
1 site
T G G C C A A C C G G T
PflMI  (719)
2 sites
C C A N N N N N T G G G G T N N N N N A C C

Sticky ends from different PflMI sites may not be compatible.
PstI  (729)
1 site
C T G C A G G A C G T C
EcoRI  (731)
1 site
G A A T T C C T T A A G
EcoRV  (739)
1 site
G A T A T C C T A T A G

EcoRV is reportedly more prone than its isoschizomer Eco32I to
delete a base after cleavage.
HindIII  (743)
1 site
A A G C T T T T C G A A
BspDI  (750)
1 site
A T C G A T T A G C T A
ClaI  (750)
1 site
A T C G A T T A G C T A
SalI  (758)
1 site
G T C G A C C A G C T G
AccI  (759)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the
recognition sequence.
Sticky ends from different AccI sites may not be compatible.
HincII  (760)
1 site
G T Y R A C C A R Y T G
AbsI  (764)
1 site
C C T C G A G G G G A G C T C C
AvaI  (764)
1 site
C Y C G R G G R G C Y C

Sticky ends from different AvaI sites may not be compatible.
BsoBI  (764)
1 site
C Y C G R G G R G C Y C

Sticky ends from different BsoBI sites may not be compatible.
BsoBI is typically used at 37°C, but can be used at temperatures
up to 65°C.
PaeR7I  (764)
1 site
C T C G A G G A G C T C

PaeR7I does not recognize the sequence CTCTCGAG.
PspXI  (764)
1 site
V C T C G A G B B G A G C T C V
XhoI  (764)
1 site
C T C G A G G A G C T C
BmeT110I  (765)
1 site
C Y C G R G G R G C Y C
EcoO109I  (773)
1 site
R G G N C C Y Y C C N G G R

Sticky ends from different EcoO109I sites may not be compatible.
PspOMI  (773)
1 site
G G G C C C C C C G G G
ApaI  (777)
1 site
G G G C C C C C C G G G

ApaI can be used between 25°C and 37°C.
Acc65I  (779)
1 site
G G T A C C C C A T G G
KpnI  (783)
1 site
G G T A C C C C A T G G
BspQI  (1061)
1 site
G C T C T T C N C G A G A A G N N N N

Sticky ends from different BspQI sites may not be compatible.
SapI  (1061)
1 site
G C T C T T C N C G A G A A G N N N N

Sticky ends from different SapI sites may not be compatible.
SapI gradually settles in solution, so a tube of SapI should be
mixed before removing an aliquot.
AflIII  (1177)
1 site
A C R Y G T T G Y R C A

Sticky ends from different AflIII sites may not be compatible.
PciI  (1177)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
NspI  (1181)
1 site
R C A T G Y Y G T A C R
AmpR
1997 .. 2857  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 2:  
   1997 .. 2788  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
AmpR
1997 .. 2857  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 1:  signal sequence  
   2789 .. 2857  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
AmpR
1997 .. 2857  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
ori
1238 .. 1826  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
ori
1238 .. 1826  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
f1 ori
4 .. 459  =  456 bp
f1 bacteriophage origin of replication; arrow
indicates direction of (+) strand synthesis
f1 ori
4 .. 459  =  456 bp
f1 bacteriophage origin of replication; arrow
indicates direction of (+) strand synthesis
MCS
653 .. 784  =  132 bp
multiple cloning site
MCS
653 .. 784  =  132 bp
multiple cloning site
AmpR promoter
2858 .. 2962  =  105 bp
AmpR promoter
2858 .. 2962  =  105 bp
lac promoter
884 .. 914  =  31 bp
   Segment 3:  -10  
   884 .. 890  =  7 bp
promoter for the E. coli lac operon
lac promoter
884 .. 914  =  31 bp
   Segment 2:  
   891 .. 908  =  18 bp
promoter for the E. coli lac operon
lac promoter
884 .. 914  =  31 bp
   Segment 1:  -35  
   909 .. 914  =  6 bp
promoter for the E. coli lac operon
lac promoter
884 .. 914  =  31 bp
3 segments
promoter for the E. coli lac operon
T7 promoter
626 .. 644  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
626 .. 644  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T3 promoter
797 .. 815  =  19 bp
promoter for bacteriophage T3 RNA polymerase
T3 promoter
797 .. 815  =  19 bp
promoter for bacteriophage T3 RNA polymerase
M13 fwd
600 .. 616  =  17 bp
common sequencing primer, one of multiple similar
variants
M13 fwd
600 .. 616  =  17 bp
common sequencing primer, one of multiple similar
variants
M13 rev
836 .. 852  =  17 bp
common sequencing primer, one of multiple similar
variants
M13 rev
836 .. 852  =  17 bp
common sequencing primer, one of multiple similar
variants
lac operator
860 .. 876  =  17 bp
The lac repressor binds to the lac operator to inhibit
transcription in E. coli. This inhibition can be
relieved by adding lactose or
isopropyl-β-D-thiogalactopyranoside (IPTG).
lac operator
860 .. 876  =  17 bp
The lac repressor binds to the lac operator to inhibit
transcription in E. coli. This inhibition can be
relieved by adding lactose or
isopropyl-β-D-thiogalactopyranoside (IPTG).
Try SnapGene and create your own beautiful maps

Individual Sequences & Maps

SnapGene offers the fastest and easiest way to plan, visualize, and document your molecular biology procedures.

Priced accessibly so that everyone in your lab can have a license.

Learn More...

SnapGene Viewer is a versatile tool for creating and sharing richly annotated sequence files. It opens many common file formats.

Free! Because there should be no barriers to seeing your data.

Learn More...

The map, notes, and annotations on this page and in the sequence/map file are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as "www.snapgene.com/resources". Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Copyright © 2016 GSL Biotech LLC | Site Map | Privacy | Legal Disclaimers   Subscribe to Our Newsletter